← Leaderboards
Sreenivasa R Chinni
Wayne State University
$1,686,802
Attributed
$1,686,802
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $310.5K · FY2010–21$500K$375K$250K$125K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$1,686,802 · 2
By mechanism
R01$1,290,829 · 1
R21$395,973 · 1
Top collaborators
No co-investigators on record.
Most similar at Wayne State University
Same institution · by research overlap
- David Oupicky$10,225,505
- Yong Q Chen$13,918,300
- Hyeong-Reh Choi Kim$17,738,970
- Izabela Podgorski$3,563,464
- Kenneth V Honn$4,506,496
Others in their field
Top investigators on “Phosphotransferases”
- David Heimbrook · Leidos Biomedical Research, Inc.$26,594,235
- Gary L. Johnson · National Jewish Health$21,727,284
- Peter Karl Sorger · Massachusetts Institute Of Technology$20,231,592
- Lewis C Cantley · Beth Israel Deaconess Medical Center$19,866,259
- Richard L Huganir · Johns Hopkins University$18,390,405
- Fulton T Crews · University Of North Carolina Chapel Hill$17,915,277
Research focus
PhosphotransferasesProstatic NeoplasmsGrowth Factor ReceptorsMembrane MicrodomainsNeoplasm MetastasisPathway InteractionsDisease ProgressionGrowthMediatingMalignant Neoplasm Of ProstateMolecularMolecular BiologyOverexpressionCxcr4 GeneBaseChemokine ReceptorGrantCellsIn VivoCancer EtiologyLinkLipidsBiologicalRegulation
Grant awards (7)
CXCL12/CXCR4 regulation of PI4KIIIalpha activity in metastatic prostate tumors$179,988
R21 · FY2021 · CA · contact PI
CXCL12/CXCR4 regulation of PI4KIIIalpha activity in metastatic prostate tumors$215,985
R21 · FY2020 · CA · contact PI
Novel ERG regulation of CXCR4 in prostate cancer progression$290,540
R01 · FY2014 · CA · contact PI
Novel ERG regulation of CXCR4 in prostate cancer progression$88,461
R01 · FY2013 · CA · contact PI
Novel ERG regulation of CXCR4 in prostate cancer progression$300,440
R01 · FY2012 · CA · contact PI
Novel ERG regulation of CXCR4 in prostate cancer progression$300,847
R01 · FY2011 · CA · contact PI
Novel ERG regulation of CXCR4 in prostate cancer progression$310,541
R01 · FY2010 · CA · contact PI